Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × TroVax × Clear all

NCT00397345 2020-10-19

TroVax Renal Immunotherapy Survival Trial

Phase 3 Completed

Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms